These targets were ... Repurposing Drug Shows Promise in Fighting Aggressive Brain Tumors Oct. 17, 2024 — Research provides evidence that a drug used to slow the progression of the disease ALS ...

Virtually every cell in the human body has an internal clock. These clocks take their cues from a central clock in the brain. In a normal, biological process called synchrony, the central clock ...

“In Canada, cancer immunotherapy for brain tumours is in early phases of development and requires proof-of-concept data. The support from Brain Cancer Canada fundraisers, donors, and philanthropists ...

Glioblastoma, an aggressive brain cancer, syncs its internal clock to the host’s circadian rhythms, leveraging daily hormone cycles for growth. Blocking these signals slowed tumor progression in mice ...

For the first time, researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

Brain Tumors Hijack Circadian Clock to Grow Dec. 12, 2024 — New research shows that glioblastoma has an internal clock and syncs its daily rhythms to match -- and take advantage of -- the ...

An international research team led by a Boston College professor has uncovered a drug and diet pairing that could fight a deadly brain cancer The international team combined a calorie-restricted diet ...

According to a study published in Oncogene, an MRI-based imaging technology developed at the University of Cambridge predicts ...

The research was published in Brain Research. According to the study, the triple-acting treatment is thought to work against Alzheimer’s disease by protecting nerve cells, reducing amyloid ...

13, 2024 (GLOBE NEWSWIRE) -- The "Blood Brain Barrier Technologies Market 2024" report has been added to ... including a ...

Earlier research has shown that ketogenic diets can facilitate delivery of small-molecule therapeutic drugs through the blood brain barrier without toxicity. The work was supported with funding from ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.